Research Article
Usefulness of Lipid Apheresis in the Treatment of Familial Hypercholesterolemia
Table 1
Patient characteristics.
| | | |
| | Age (years), mean (SD) | 65.6 (9.3) | | Male, (%) | 8 (72.7) | | BMI (kg/m2), mean (SD) | 30.0 (5.3) | | Current smoker, (%) | 1 (9.1) | | Former smoker, (%) | 2 (18.2) | | Diabetes, (%) | 2 (18.2) | | Hypertension, (%) | 4 (36.4) | | Blood pressure before apheresis | | | Systolic (mmHg), mean (SD) | 136.9 (16.3) | | Diastolic (mmHg), mean (SD) | 79.5 (6.7) | | Blood pressure after apheresis | | | Systolic (mmHg), mean (SD) | 133.0 (13.3) | | Diastolic (mmHg), mean (SD) | 70.2 (8.1) | | Statin intolerant, (%) | 7 (63.6) | | Cholesterol medication before apheresis | | | Statin, (%) | 5 (45.5) | | Nonstatin, (%) | 4 (36.6) | | Cholesterol medication after apheresis | | | Statin, (%) | 4 (36.6) | | Nonstatin, (%) | 5 (45.5) |
|
|
